{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T20:29:51Z","timestamp":1773952191565,"version":"3.50.1"},"reference-count":22,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,1,1]]},"abstract":"<jats:p>OBJECTIVES. Our goals were (1) to determine the use of medications to treat gastroesophageal reflux in extremely low birth weight infants (birth weight of &amp;lt;1000 g) at discharge; (2) to identify risk factors associated with the use of medications to treat gastroesophageal reflux at discharge; and (3) to assess the contribution of gastroesophageal reflux medication use at discharge to growth and development at corrected ages of 18 to 22 months.<\/jats:p>\n               <jats:p>METHODS. This retrospective cohort analysis included extremely low birth weight infants enrolled at National Institute of Child Health and Human Development Neonatal Research Network Centers between 2002 and 2003 who survived to follow-up evaluations at corrected ages of 18 to 22 months. Analyses were used to identify factors associated with discharge with antireflux medications and poor growth or neurodevelopmental impairment after discharge.<\/jats:p>\n               <jats:p>RESULTS. A total of 1598 infants were included in the analyses; 24.8% were discharged from the hospital with medications to treat gastroesophageal reflux. A total of 19.3% of the 1287 infants discharged at postmenstrual age of \u226442 weeks were discharged with antireflux medications. For those infants, center, lower gestational age, and race had significant effects on the use of antireflux medications at discharge. A total of 47.6% of the 311 infants discharged at postmenstrual age of &amp;gt;42 weeks were discharged with antireflux medications. For those infants, no tested variables were associated with treatment with antireflux medications at discharge. Use of antireflux medications at discharge was not associated with either poor growth or neurodevelopmental impairment at corrected ages of 18 to 22 months.<\/jats:p>\n               <jats:p>CONCLUSIONS. Use of antireflux medications at the time of discharge seems to be common for extremely low birth weight infants, especially those discharged at postmenstrual age of &amp;gt;42 weeks, but does not seem to have effects on growth or development at the time of follow-up evaluations.<\/jats:p>","DOI":"10.1542\/peds.2007-0381","type":"journal-article","created":{"date-parts":[[2007,12,31]],"date-time":"2007-12-31T17:23:13Z","timestamp":1199121793000},"page":"22-27","source":"Crossref","is-referenced-by-count":97,"title":["Use of Medications for Gastroesophageal Reflux at Discharge Among Extremely Low Birth Weight Infants"],"prefix":"10.1542","volume":"121","author":[{"given":"William F.","family":"Malcolm","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Duke University, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Gantz","sequence":"additional","affiliation":[{"name":"Research Triangle Institute International, Research Triangle Park, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Martin","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Case Western Reserve University, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricki F.","family":"Goldstein","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Duke University, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald N.","family":"Goldberg","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Duke University, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles M.","family":"Cotten","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Duke University, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the National Institute of Child Health and Human Development Neonatal Research Network","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2008,1,1]]},"reference":[{"key":"2021120902203500700_R1","doi-asserted-by":"crossref","unstructured":"Peter CS, Sprodowski N, Bohnhorst B, Silny J, Poets CF. Gastroesophageal reflux and apnea of prematurity: no temporal relationship. Pediatrics.\u20082002;109:8\u201311","DOI":"10.1542\/peds.109.1.8"},{"key":"2021120902203500700_R2","doi-asserted-by":"crossref","unstructured":"Barrington KJ, Tan K, Rich W. Apnea at discharge and gastro-esophageal reflux in the preterm infant. J Perinatol.\u20082002;22:8\u201311","DOI":"10.1038\/sj.jp.7210609"},{"key":"2021120902203500700_R3","doi-asserted-by":"crossref","unstructured":"Molloy EJ, Di Fiore JM, Martin RJ. Does gastroesophageal reflux cause apnea in preterm infants?Biol Neonate.\u20082005;87:254\u2013261","DOI":"10.1159\/000083958"},{"key":"2021120902203500700_R4","doi-asserted-by":"crossref","unstructured":"Kimball AL, Carlton DP. Gastroesophageal reflux medications in the treatment of apnea in premature infants. J Pediatr.\u20082001;138:355\u2013360","DOI":"10.1067\/mpd.2001.111324"},{"key":"2021120902203500700_R5","doi-asserted-by":"crossref","unstructured":"Snel A, Barnett CP, Cresp TL, et al. Behavior and gastroesophageal reflux in the premature neonate. J Pediatr Gastroenterol Nutr.\u20082000;30:18\u201321","DOI":"10.1097\/00005176-200001000-00012"},{"key":"2021120902203500700_R6","doi-asserted-by":"crossref","unstructured":"Frakaloss G, Burke G, Sanders MR. Impact of gastroesophageal reflux on growth and hospital stay in premature infants. J Pediatr Gastroenterol Nutr.\u20081998;26:146\u2013150","DOI":"10.1097\/00005176-199802000-00005"},{"key":"2021120902203500700_R7","unstructured":"Ferlauto JJ, Walker MW, Martin MS. Clinically significant gastroesophageal reflux in the at-risk premature neonate: relation to cognitive scores, days in the NICU, and total hospital charges. J Perinatol.\u20081998;18:455\u2013459"},{"key":"2021120902203500700_R8","doi-asserted-by":"crossref","unstructured":"Clark RH, Bloom BT, Spitzer AR, Gerstmann DR. Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics.\u20082006;117:1979\u20131987","DOI":"10.1542\/peds.2005-1707"},{"key":"2021120902203500700_R9","doi-asserted-by":"crossref","unstructured":"Guillet R, Stoll BJ, Cotten CM, et al. Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics.\u20082006;117(2). Available at: www.pediatrics.org\/cgi\/content\/full\/117\/2\/e137","DOI":"10.1542\/peds.2005-1543"},{"key":"2021120902203500700_R10","unstructured":"Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data.\u20082000;(314):1\u201327"},{"key":"2021120902203500700_R11","unstructured":"Bayley N. Manual for the Bayley Scales of Infant Development. 2nd ed. San Antonio, TX: Psychological Corp; 1993"},{"key":"2021120902203500700_R12","doi-asserted-by":"crossref","unstructured":"Cotten CM, Oh W, McDonald S, et al. Prolonged hospital stay for extremely premature infants: risk factors, center differences, and the impact of mortality on selecting a best-performing center. J Perinatol.\u20082005;25:650\u2013655","DOI":"10.1038\/sj.jp.7211369"},{"key":"2021120902203500700_R13","doi-asserted-by":"crossref","unstructured":"Tyson JE, Younes N, Verter J, Wright LL. Viability, morbidity, and resource use among newborns of 501- to 800-g birth weight. JAMA.\u20081996;276:1645\u20131651","DOI":"10.1001\/jama.276.20.1645"},{"key":"2021120902203500700_R14","doi-asserted-by":"crossref","unstructured":"Rudolph CD, Mazur LJ, Liptak GS, et al. Pediatric gastroesophageal reflux clinical practice guidelines. J Pediatr Gastroenterol Nutr.\u20082001;32(suppl 2):1\u201331","DOI":"10.1097\/00005176-200100002-00001"},{"key":"2021120902203500700_R15","doi-asserted-by":"crossref","unstructured":"Mehall JR, Kite CA, Saltzman DA, Wallett T, Jackson RJ, Smith SD. Prospective study of the incidence and complications of bacterial contamination of enteral feeding in neonates. J Pediatr Surg.\u20082002;37:1177\u20131182","DOI":"10.1053\/jpsu.2002.34467"},{"key":"2021120902203500700_R16","doi-asserted-by":"crossref","unstructured":"Hibbs AM, Lorch SA. Metoclopramide for the treatment of gastroesophageal reflux disease in infants: a systematic review. Pediatrics.\u20082006;118:746\u2013752","DOI":"10.1542\/peds.2005-2664"},{"key":"2021120902203500700_R17","doi-asserted-by":"crossref","unstructured":"Dhillon AS, Ewer AK. Diagnosis and management of gastro-oesophageal reflux in preterm infants in neonatal intensive care units. Acta Paediatr.\u20082004;93:88\u201393","DOI":"10.1111\/j.1651-2227.2004.tb00680.x"},{"key":"2021120902203500700_R18","doi-asserted-by":"crossref","unstructured":"Fanaroff AA, Stoll BJ, Wright LL, et al. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol.\u20082007;196:147.e1\u2013147.e8","DOI":"10.1016\/j.ajog.2006.09.014"},{"key":"2021120902203500700_R19","doi-asserted-by":"crossref","unstructured":"Wenzl TG, Moroder C, Trachterna M, et al. Esophageal pH monitoring and impedance measurement: a comparison of two diagnostic tests for gastroesophageal reflux. J Pediatr Gastroenterol Nutr.\u20082002;34:519\u2013523","DOI":"10.1097\/00005176-200205000-00009"},{"key":"2021120902203500700_R20","doi-asserted-by":"crossref","unstructured":"Latal-Hajnal B, von Siebenthal K, Kovari H, Bucher HU, Largo RH. Postnatal growth in VLBW infants: significant association with neurodevelopmental outcome. J Pediatr.\u20082003;143:163\u2013170","DOI":"10.1067\/S0022-3476(03)00243-9"},{"key":"2021120902203500700_R21","doi-asserted-by":"crossref","unstructured":"Reilly S, Skuse D, Poblete X. Prevalence of feeding problems and oral motor dysfunction in children with cerebral palsy: a community survey. J Pediatr.\u20081996;129:877\u2013882","DOI":"10.1016\/S0022-3476(96)70032-X"},{"key":"2021120902203500700_R22","doi-asserted-by":"crossref","unstructured":"Mizuno K, Ueda A. Neonatal feeding performance as a predictor of neurodevelopmental outcome at 18 months. Dev Med Child Neurol.\u20082005;47:299\u2013304","DOI":"10.1017\/S0012162205000587"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/121\/1\/22\/1121964\/zpe00108000022.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/121\/1\/22\/1121964\/zpe00108000022.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T11:22:02Z","timestamp":1639048922000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/121\/1\/22\/71046\/Use-of-Medications-for-Gastroesophageal-Reflux-at"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,1]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,1,1]]},"published-print":{"date-parts":[[2008,1,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2007-0381","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,1]]}}}